Apyx Medical Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 20.7 | 63.8 | – | – | 18.9 | 14.9 | – | 62.0 | 27.8 | 116.3 | 57.3 | 47.1 | 57.8 | 233.6 | – | 340.4 | 69.2 | – | – | – | – | – | 3.5 | – | – | – | – | – | – | – | |
| 1.1 | 0.9 | 1.1 | 1.6 | 1.0 | 1.0 | 1.1 | 2.6 | 2.0 | 2.3 | 5.8 | 3.9 | 3.8 | 5.2 | 2.4 | 1.5 | 1.5 | 1.6 | 2.4 | 2.0 | 2.7 | 2.1 | 13.4 | 10.3 | 8.9 | 9.1 | 1.8 | 1.7 | 1.2 | 2.8 | |
| 4.2 | 2.8 | 1.0 | 2.5 | 1.5 | 1.7 | 2.2 | 5.7 | 4.5 | 4.8 | 10.9 | 6.7 | 5.6 | 6.6 | 2.6 | 1.7 | 1.9 | 1.8 | 14.0 | 2.5 | 3.8 | 3.7 | 2.5 | 4.1 | 3.9 | 8.2 | 2.1 | 3.4 | 4.0 | 10.1 | |
| 1.1 | 1.0 | 1.2 | 1.6 | 1.0 | 1.0 | 1.2 | 2.6 | 2.0 | 2.3 | 5.7 | 3.8 | 3.8 | 5.3 | 2.4 | 1.4 | 1.5 | 1.7 | 2.7 | 1.7 | 2.4 | 1.9 | 12.4 | 8.2 | 7.4 | 8.4 | 1.6 | 1.5 | 1.2 | 2.9 | |
| 11.5 | 11.5 | – | 16.4 | 10.6 | 10.2 | – | 38.2 | 24.0 | 48.7 | 47.9 | 38.4 | 28.2 | 79.3 | – | 30.1 | 21.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | 37.8 | 23.6 | 15.2 | – | – | 29.2 | – | 301.0 | 345.1 | – | – | – | 27.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.4% | -5.6% | -3.5% | 2.6% | 4.2% | 6.6% | -1.0% | -0.4% | 3.4% | -2.3% | 0.3% | 0.3% | -3.6% | -1.8% | -1.3% | 3.7% | -1.4% | -8.0% | -1.6% | -10.7% | -3.2% | -5.3% | -9.6% | -6.8% | -6.8% | -2.5% | -26.8% | -6.4% | -33.0% | -6.2% | |
| Margins | ||||||||||||||||||||||||||||||
| 44.8% | 43.9% | 37.5% | 52.2% | 53.7% | 50.2% | 42.2% | 43.0% | 38.9% | 37.4% | 39.7% | 39.3% | 42.2% | 44.0% | 41.2% | 42.2% | 41.0% | 38.9% | 32.5% | 42.5% | 48.9% | 50.8% | 64.7% | 67.6% | 63.2% | 69.3% | 65.4% | 64.5% | 61.0% | 36.0% | |
| 6.4% | 4.6% | -10.9% | -22.4% | 5.3% | 5.1% | -3.8% | 4.3% | 6.2% | 2.0% | 9.8% | 7.3% | 4.6% | 2.7% | -11.4% | -0.1% | 3.8% | -15.5% | -21.1% | -23.7% | -10.4% | -13.5% | -81.5% | -73.9% | -72.5% | -29.8% | -52.9% | -33.0% | -39.2% | -12.2% | |
| 5.4% | 1.3% | -11.8% | -22.8% | 5.0% | 6.8% | -4.1% | 4.1% | 7.4% | 2.0% | 10.1% | 8.3% | 6.5% | 2.2% | -6.3% | 0.4% | 2.2% | -18.3% | -62.4% | -18.2% | -10.8% | -13.0% | 383.6% | -69.8% | -42.9% | -31.3% | -52.1% | -35.7% | -48.8% | -21.2% | |
| -0.4% | -4.8% | -4.0% | 4.2% | 4.0% | 6.7% | -1.2% | -0.9% | 7.0% | -5.4% | 1.9% | 1.1% | -13.5% | -9.5% | -3.2% | 5.3% | -2.1% | -13.2% | -3.8% | -21.0% | -8.5% | -11.1% | -128.1% | -70.0% | -60.1% | -23.0% | -47.8% | -11.0% | -39.0% | -17.2% | |
| Returns | ||||||||||||||||||||||||||||||
| 20.2% | 4.5% | -10.7% | -36.3% | 7.8% | 11.2% | -7.9% | 9.1% | 16.3% | 4.1% | 19.1% | 14.3% | 9.7% | 2.8% | -7.1% | 0.5% | 2.7% | -20.3% | -368.2% | -22.9% | -15.1% | -23.0% | 72.9% | -27.7% | -18.7% | -28.3% | -61.7% | -70.1% | -165.1% | -77.1% | |
| 10.4% | 2.6% | -9.4% | -29.7% | 6.3% | 9.1% | -6.1% | 7.4% | 13.7% | 3.5% | 16.1% | 12.8% | 7.1% | 2.2% | -5.5% | 0.4% | 2.2% | -13.1% | -69.6% | -17.1% | -11.3% | -16.3% | 66.9% | -23.3% | -16.1% | -22.1% | -44.8% | -23.6% | -36.2% | -16.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| 0.1 | 0.8 | 0.3 | 0.2 | 0.3 | 0.1 | 0.6 | 0.1 | -1.9 | -0.9 | -2.8 | -2.8 | 1.5 | 2.7 | 0.0 | -1.2 | -0.7 | 1.1 | 10 | -8.2 | -11 | -7.1 | -16 | -58 | -42 | -31 | -9.9 | -10 | 2.5 | 3.5 | |
| 0.1 | 1.2 | – | 0.3 | 0.3 | 0.1 | – | 0.1 | -1.1 | -1.0 | -0.9 | -1.0 | 0.4 | 1.5 | – | -1.0 | -0.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 51.8% | 58.0% | 87.1% | 81.9% | 80.8% | 81.6% | 76.4% | 80.7% | 84.0% | 83.3% | 84.3% | 89.2% | 72.9% | 76.7% | 78.3% | 78.3% | 81.2% | 64.3% | 18.9% | 74.4% | 74.7% | 71.1% | 91.8% | 84.2% | 86.0% | 78.1% | 72.6% | 33.7% | 21.9% | 21.8% | |
| 0.1 | 0.4 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 3.4 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 2.4 | 2.4 | |
| Per Share | ||||||||||||||||||||||||||||||
| 0.05 | 0.01 | -0.07 | -0.16 | 0.03 | 0.05 | -0.04 | 0.05 | 0.09 | 0.03 | 0.16 | 0.14 | 0.11 | 0.03 | -0.09 | 0.01 | 0.03 | -0.25 | -0.97 | -0.19 | -0.14 | -0.16 | 1.86 | -0.58 | -0.35 | -0.44 | -0.67 | -0.54 | -0.66 | -0.27 | |
| 0.98 | 0.87 | 0.61 | 0.69 | 0.62 | 0.78 | 0.86 | 1.21 | 1.22 | 1.28 | 1.58 | 1.63 | 1.64 | 1.51 | 1.40 | 1.44 | 1.56 | 1.34 | 1.56 | 1.06 | 1.33 | 1.24 | 0.49 | 0.83 | 0.81 | 1.41 | 1.29 | 1.51 | 1.35 | 1.25 | |
| 0.26 | 0.26 | 0.67 | 0.43 | 0.40 | 0.47 | 0.45 | 0.55 | 0.55 | 0.62 | 0.83 | 0.95 | 1.10 | 1.19 | 1.25 | 1.25 | 1.29 | 1.21 | 0.26 | 0.84 | 0.96 | 0.70 | 2.55 | 2.09 | 1.86 | 1.56 | 1.09 | 0.77 | 0.40 | 0.34 | |
| 0.00 | -0.04 | -0.02 | 0.03 | 0.02 | 0.05 | -0.01 | -0.01 | 0.09 | -0.07 | 0.03 | 0.02 | -0.22 | -0.14 | -0.04 | 0.08 | -0.03 | -0.18 | -0.06 | -0.22 | -0.11 | -0.14 | -0.62 | -0.58 | -0.49 | -0.33 | -0.62 | -0.17 | -0.53 | -0.22 | |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.